or Try an Advanced Search...

    Technical Analysis for NTRB - Nutriband Inc.

    Grade Last Price % Change Price Change
    D 4.82 -3.21% -0.16
    NTRB closed up 1.43 percent on Wednesday, November 20, 2024, on 39 percent of normal volume. It was able to bounce off of its 200 day moving average, an important long-term support line. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    Earnings due: Dec 10
    *** please verify all earnings dates ***
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical NTRB trend table...
    Date Alert Name Type % Chg
    200 DMA Support Bullish -3.21%
    Inside Day Range Contraction -3.21%
    Wide Bands Range Expansion -3.21%
    Oversold Stochastic Weakness -3.21%
    200 DMA Support Bullish -1.83%
    Wide Bands Range Expansion -1.83%
    Gapped Down Weakness -1.83%
    Oversold Stochastic Weakness -1.83%
    Crossed Above 200 DMA Bullish -2.82%
    Wide Bands Range Expansion -2.82%
    Older End-of-Day Signals for NTRB ...

       Recent Intraday Alerts

    Alert Time
    Rose Above Previous Day's High about 3 hours ago
    10 DMA Resistance about 3 hours ago
    Outside Day about 3 hours ago
    Down 5% about 3 hours ago
    Down 3% about 3 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    NTRB Chart by TradingView
    Basic chart:

    Profile

    The Company is primarily engaged in the development of a portfolio of transdermal pharmaceutical products. Its lead product under development is its abuse deterrent fentanyl transdermal system which the Company is developing to provide clinicians and patients with an abuse deterrent transdermal fentanyl product for use in managing chronic pain requiring opioid therapy. The product is combined with properties designed to help combat the opioid crisis by deterring the abuse and misuse of fentanyl patches
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Euphoriants Opioids Chronic Pain Analgesics Heroin Morphine Fentanyl Anilides Semisynthetic Opioids

    Is NTRB a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 3 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Oct 31 Nutriband Inc. Issued Full Patent from the Chinese National Intellectual Property Administrant for Its "Abuse and Misuse Deterrent Transdermal System" Application
    Oct 2 Join Nutriband's Exclusive Live Investor Webinar and Q&A Session on October 17
    Sep 24 Nutriband Receives China Patent Notice of Allowance for Its Aversa(TM) Abuse Deterrent Transdermal Technology
    Sep 20 Nutriband Licenses Bitrex(R) Brand Aversive Agent for Its Lead Product - Aversa(TM) Fentanyl Transdermal Patch
    Sep 17 Microsoft, Intel And 3 Stocks To Watch Heading Into Tuesday
    Aug 1 Nutriband (NASDAQ:NTRB investor five-year losses grow to 80% as the stock sheds US$27m this past week
    Jul 19 Join Nutriband's Exclusive Live Investor Webinar and Q&A Session on July 25
    Jul 15 Nutriband Receives Notice of Allowance for U.S. Trademark Covering AVERSA(TM) Abuse Deterrent Technology
    Jun 20 Nutriband Provides Product Development Update for Its Lead Product Aversa Fentanyl
    Jun 3 Nutriband Inc. Quarterly Report Emphasizes Focus on Kinesiology Tape Output as Q1 Sports Tape Revenues Increase 219% Year Over Year
    See more NTRB news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 9.595
    52 Week Low 2.22
    Average Volume 33,305
    200-Day Moving Average 4.88
    50-Day Moving Average 5.93
    20-Day Moving Average 5.46
    10-Day Moving Average 5.01
    Average True Range 0.48
    RSI (14) 40.48
    ADX 26.67
    +DI 12.20
    -DI 23.02
    Chandelier Exit (Long, 3 ATRs) 4.96
    Chandelier Exit (Short, 3 ATRs) 6.07
    Upper Bollinger Bands 6.53
    Lower Bollinger Band 4.40
    Percent B (%b) 0.27
    BandWidth 39.05
    MACD Line -0.36
    MACD Signal Line -0.30
    MACD Histogram -0.0552
    Fundamentals Value
    Market Cap 42.13 Million
    Num Shares 8.46 Million
    EPS -0.67
    Price-to-Earnings (P/E) Ratio -7.43
    Price-to-Sales 10.45
    Price-to-Book 3.72
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 5.45
    Resistance 3 (R3) 5.44 5.27 5.37
    Resistance 2 (R2) 5.27 5.15 5.28 5.34
    Resistance 1 (R1) 5.13 5.08 5.20 5.14 5.32
    Pivot Point 4.96 4.96 5.00 4.97 4.96
    Support 1 (S1) 4.82 4.84 4.89 4.83 4.64
    Support 2 (S2) 4.65 4.77 4.66 4.62
    Support 3 (S3) 4.51 4.65 4.59
    Support 4 (S4) 4.52